Smith 2013b

Trial name or title	Varenicline for cognitive deficits and cigarette smoking in schizophrenia
Methods	Randomised double‐blind placebo‐controlled trial
Participants	60 adult smokers with schizophrenia
Interventions	Varenicline 1 ‐ 2 mg/day vs placebo
Outcomes	Cotinine‐verified cessation, + Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS), Positive and Negative Syndrome Scale (PANNS), Hamilton Depression Scale
Starting date	September 2008
Contact information	RC Smith
Notes